228 related articles for article (PubMed ID: 15713105)
1. Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor.
Haes AJ; Chang L; Klein WL; Van Duyne RP
J Am Chem Soc; 2005 Feb; 127(7):2264-71. PubMed ID: 15713105
[TBL] [Abstract][Full Text] [Related]
2. The immune system, amyloid-beta peptide, and Alzheimer's disease.
Weksler ME; Gouras G; Relkin NR; Szabo P
Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibodies against amyloid-beta from healthy adults.
Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M
Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434
[TBL] [Abstract][Full Text] [Related]
4. Localized surface plasmon resonance biosensors.
Zhao J; Zhang X; Yonzon CR; Haes AJ; Van Duyne RP
Nanomedicine (Lond); 2006 Aug; 1(2):219-28. PubMed ID: 17716111
[TBL] [Abstract][Full Text] [Related]
5. En route to early diagnosis of Alzheimer's disease--are we there yet?
Fradinger EA; Bitan G
Trends Biotechnol; 2005 Nov; 23(11):531-3. PubMed ID: 16165236
[TBL] [Abstract][Full Text] [Related]
6. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
Solomon B
Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
[TBL] [Abstract][Full Text] [Related]
7. Electrical detection of beta-amyloid (1-40) using scanning tunneling microscopy.
Lee JH; Kang DY; Kim SU; Yea CH; Oh BK; Choi JW
Ultramicroscopy; 2009 Jul; 109(8):923-8. PubMed ID: 19345496
[TBL] [Abstract][Full Text] [Related]
8. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
9. Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients.
Henkel AW; Dittrich PS; Groemer TW; Lemke EA; Klingauf J; Klafki HW; Lewczuk P; Esselmann H; Schwille P; Kornhuber J; Wiltfang J
Mol Psychiatry; 2007 Jun; 12(6):601-10. PubMed ID: 17279093
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
11. Quantification of amyloid-beta 40 in cerebrospinal fluid.
Verwey NA; Veerhuis R; Twaalfhoven HA; Wouters D; Hoozemans JJ; Bollen YJ; Killestein J; Bibl M; Wiltfang J; Hack CE; Scheltens P; Blankenstein MA
J Immunol Methods; 2009 Aug; 348(1-2):57-66. PubMed ID: 19576899
[TBL] [Abstract][Full Text] [Related]
12. Label-free cell-based assay using localized surface plasmon resonance biosensor.
Endo T; Yamamura S; Kerman K; Tamiya E
Anal Chim Acta; 2008 May; 614(2):182-9. PubMed ID: 18420049
[TBL] [Abstract][Full Text] [Related]
13. Plasma beta carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2005 Dec; 26(6):696-8. PubMed ID: 16380679
[TBL] [Abstract][Full Text] [Related]
14. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons.
Shughrue PJ; Acton PJ; Breese RS; Zhao WQ; Chen-Dodson E; Hepler RW; Wolfe AL; Matthews M; Heidecker GJ; Joyce JG; Villarreal SA; Kinney GG
Neurobiol Aging; 2010 Feb; 31(2):189-202. PubMed ID: 18486276
[TBL] [Abstract][Full Text] [Related]
15. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
[TBL] [Abstract][Full Text] [Related]
16. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.
Nilselid AM; Davidsson P; Nägga K; Andreasen N; Fredman P; Blennow K
Neurochem Int; 2006 Jun; 48(8):718-28. PubMed ID: 16490286
[TBL] [Abstract][Full Text] [Related]
17. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P
Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
[TBL] [Abstract][Full Text] [Related]
18. Localized surface plasmon resonance biosensor integrated with microfluidic chip.
Huang C; Bonroy K; Reekmans G; Laureyn W; Verhaegen K; De Vlaminck I; Lagae L; Borghs G
Biomed Microdevices; 2009 Aug; 11(4):893-901. PubMed ID: 19353272
[TBL] [Abstract][Full Text] [Related]
19. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
20. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
